XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development, net of grant reimbursement $ 22,120 $ 14,906
General and administrative 4,392 2,915
Total operating expenses 26,512 17,821
Operating loss (26,512) (17,821)
Interest income 2,051 31
Other income, net 190 263
Net loss $ (24,271) $ (17,527)
Net income (loss) per share    
Net loss per share, Diluted $ (0.58) $ (0.44)
Weighted-average shares used in computing net income (loss) per share    
Shares used in computing net loss per share, diluted 41,739 39,962